関根 郁夫(セキネ イクオ)

研究者情報全体を表示

論文
  • Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung.
    Sekine Ikuo
    Jpn J Clin Oncol/37(7)/pp.482-486, 2007-07
    PubMed
  • Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years of age or older
    Sekine Ikuo
    Jpn J Clin Oncol/37(3)/pp.181-185, 2007-04
    PubMed
  • Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib
    Sekine Ikuo
    Clin Cancer Res/13(18 Pt 1)/pp.5385-5390, 2007-09
    PubMed
  • Genetic Variations of VDR/NR1I1 Encoding Vitamin D Receptor in a Japanese Population
    Sekine Ikuo
    Drug Metab Pharmacokinet/22(6)/pp.462-467, 2007-12
    PubMed
  • Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer
    Sekine Ikuo
    Clin Cancer Res/14(15)/pp.4751-4757, 2008-08
    PubMed
  • Influence of previous chemotherapy on the efficacy of subsequent docetaxel therapy in advanced non-small cell lung cancer patients
    Sekine Ikuo
    J Thorac Oncol/3(4)/pp.412-416, 2008-04
    PubMed
  • EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan.
    Sekine Ikuo
    J Clin Oncol/26(34)/pp.5589-5595, 2008-09
    PubMed
  • Gender differences in treatment outcomes among patients with non-small cell lung cancer given a combination of carboplatin and paclitaxel
    Sekine Ikuo
    Oncology/75(3-4)/pp.169-174, 2008-10
    PubMed
  • Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC) treated with radiotherapy using conventional fields and doses.
    Sekine Ikuo
    Radiother Oncol/91(3)/pp.433-437, 2009-06
    PubMed
  • Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel
    Sekine Ikuo
    J Thorac Oncol/4(2)/pp.208-213, 2009-02
    PubMed
  • PhaseⅢtrial of palonosetron plus dexamethasone versus granisetron plus dexamethasone for the prevention of nausea and vomiting during cancer chemotherapy
    Sekine Ikuo
    Lancet Oncol/10(2)/pp.115-124, 2009-01
    PubMed
  • Genetic variations and haplotype structures of the glutathione S-transferase genes, GSTT1 and GSTM1, in a Japanese patient population
    Sekine Ikuo
    Drug Metab Pharmacokinet/24(1)/pp.118-126, 2009-01
    PubMed
  • Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials
    Sekine Ikuo
    Br J Cancer/100(7)/pp.1037-1042, 2009-03
    PubMed
  • A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer
    Sekine Ikuo
    Cancer Chemother Pharmacol 65:79-88, 2009/65(1)/pp.79-88, 2009-04
    PubMed
  • A Pharmacokinetic and Dose Escalation Study of Pegfilgrastim (KRN125) in Lung Cancer Patients with Chemotherapy-induced Neutropenia
    Sekine Ikuo
    Jpn J Clin Oncol/39(7)/pp.425-430, 2009-04
    PubMed
  • A phase II dose-ranging study of palonosetron, a 5HT3 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting (CINV), in Japanese patients receiving highly emetogenic chemotherapy
    Sekine Ikuo
    Ann Oncol/20(11)/pp.1860-1866, 2009-06
    PubMed
  • A phase II dose-ranging study of palonosetron, a novel 5HT3 receptor antagonist, in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline-cyclophosphamide based chemotherapy
    Sekine Ikuo
    Ann Oncol/20(11)/pp.1874-1880, 2009-07
    PubMed
  • Differences in the quality of information on the internet about lung cancer between the United States and Japan
    Sekine Ikuo
    J Thorac Oncol/4(7)/pp.829-833, 2009-07
    PubMed
  • Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer
    Sekine Ikuo
    Cancer Sci/101(1)/pp.188-195, 2009-09
    PubMed
  • Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer
    Sekine Ikuo
    J Clin Oncol/28(33)/pp.4945-4952, 2010-10
    PubMed
  • Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component
    Sekine Ikuo
    Lung Cancer/72(3)/pp.309-315, 2010-10
    PubMed
  • The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinoma
    Sekine Ikuo
    Lung Cancer/73(1)/pp.45-50, 2010-12
    PubMed
  • Safety of BLP25 Liposome Vaccine (L-BLP25) in Japanese Patients with Unresectable Stage III NSCLC after Primary Chemoradiotherapy: Preliminary Results from a Phase I/II Study
    Sekine Ikuo
    Jpn J Clin Oncol/41(5)/pp.718-722, 2011-03
  • Amrubicin Monotherapy for Patients with Previously Treated Advanced Large-cell Neuroendocrine Carcinoma of the Lung
    Sekine Ikuo
    Jpn J Clin Oncol/41(7)/pp.897-901, 2011-06
    PubMed
  • Genetic variations of orosomucoid genes associated with serum alpha-1-acid glycoprotein level and the pharmacokinetics of paclitaxel in Japanese cancer patients
    Sekine Ikuo
    J Pharm Sci/100(10)/pp.4546-4559, 2011-06
    PubMed
  • さらに表示...